Unlocking KRAS: Turning Science into Survival - Pancreatic Cancer Action Network
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Pancreatic Cancer Action Network
Related articles
KRAS inhibition combined with CTLA-4 blockade overcomes immunotherapy resistance in KRAS-mutant gastric cancer - EurekAlert!
image: KRAS mutation drives a TGF-beta-dependent, Treg-dominant immunosuppressive microenvironment. Combination of the KRASG12D inhibitor with CTLA-4 blockade suppresses TGF-beta signaling, impairs regulatory T cell function and restores effective antitumor immunity. KRAS mutations define a distinct molecular subset of gastric adenocarcinoma (GA), yet how oncogenic KRAS shapes the gastric tumor immune microenvironment - and drives resistance to immunotherapy - has remained poorly understood. KRAS alterations occur in approximately 10% of GA, functioning not only as potent oncogenic drivers but also as regulators of the tumor microenvironment.
We’re finally unlocking the biggest mysteries of the clitoris - BBC Science Focus Magazine
The clitoris is one of the most mysterious parts of the human body. Not because it’s some strange, unknowable organ that can never be understood. But because historically medical research hasn’t really tried to.
Simulations explore nuclear mitigation of asteroid threats - Phys.org
Lawrence Livermore National Laboratory researcher Isaiah Santistevan led the development of three-dimensional simulations exploring how a nuclear device could deflect or disrupt an asteroid threatening Earth. Credit: Blaise Douros/LLNL Lawrence Livermore National Laboratory (LLNL) researchers are developing three-dimensional simulations to examine how a nuclear device could be used to deflect or potentially disrupt an asteroid threatening Earth.
0 comments
No comments yet. Be the first to share your thoughts!